Component

Femoral arterial fluorine-18 sodium fluoride PET activity

Femoral arterial fluorine-18 sodium fluoride PET activity. Species, exposure and limitations are retained in each linked claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. The between-group PET activity estimate favored an increase of 0.25 (95% CI -0.02 to 0.51; P=0.06); CT calcium-mass differences were also nonsignificant.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/k2-research/31387121.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "669c0cd660524535123c231e46bba36d26e632210055aa863a3601f3c7da9621", "start_char": 0, "end_char": 2207, "text_sha256": "669c0cd660524535123c231e46bba36d26e632210055aa863a3601f3c7da9621"}
    experimental_model
    Six-month randomized double-blind trial
    exposure
    MK-7 360 micrograms/day
    limitations
    Small trial, 60 completed; PET activity and CT calcium mass are distinct. A nonsignificant trend is not a demonstrated increase in disease.
    nutrient_topic
    Vitamin K2 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin K2 / menaquinone family
    organism
    68 adults with type 2 diabetes and established cardiovascular disease
    plain_language
    This study did not show the hoped-for imaging improvement despite a better biomarker.
    primary_references
    [k2-p31387121] The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes: a randomized, double-blind, placebo-controlled trial. (2019). https://pubmed.ncbi.nlm.nih.gov/31387121/ DOI: 10.1093/ajcn/nqz147
    tissue_or_cell_type
    Femoral fluorine-18 NaF PET and CT

    Vitamin K2: menaquinone forms, carboxylation, recycling and nutrient interactions (2026-09-17) · lines 1189–1200

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Six-month randomized double-blind trial · source_derived_draft · unverified_draft

    ### k2-diabetes-imaging The between-group PET activity estimate favored an increase of 0.25 (95% CI -0.02 to 0.51; P=0.06); CT calcium-mass differences were also nonsignificant. Condition category: normal nutrient_topic: Vitamin K2 research collection; topical membership is not evidence of a direct dietary effect. plain_language: This study did not show the hoped-for imaging improvement despite a better biomarker. organism: 68 adults with type 2 diabetes and established cardiovascular disease tissue_or_cell_type: Femoral fluorine-18 NaF PET and CT experimental_model: Six-month randomized double-blind trial limitations: Small trial, 60 completed; PET activity and CT calcium mass are distinct. A nonsignificant trend is not a demonstrated increase in disease. exposure: MK-7 360 micrograms/day evidence_span: {"source_cache": "artifacts/k2-research/31387121.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "669c0cd660524535123c231e46bba36d26e632210055aa863a3601f3c7da9621", "start_char": 0, "end_char": 2207, "text_sha256": "669c0cd660524535123c231e46bba36d26e632210055aa863a3601f3c7da9621"} [k2-p31387121] The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes: a randomized, double-blind, placebo-controlled trial. (2019). https://pubmed.ncbi.nlm.nih.gov/31387121/ DOI: 10.1093/ajcn/nqz147
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards